SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-051344
Filing Date
2023-04-27
Accepted
2023-04-27 16:14:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm232131d3_defa14a.htm DEFA14A 12765
2 GRAPHIC tm232131d3_defa14a-img001.jpg GRAPHIC 156457
3 GRAPHIC tm232131d3_defa14a-img002.jpg GRAPHIC 103859
  Complete submission text file 0001104659-23-051344.txt   372616
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40536 | Film No.: 23857039
SIC: 2834 Pharmaceutical Preparations